Core Scientific director buys 7,000 shares at $19.19

Core Scientific, Inc./tx (CORZ) director Eric Stanton Weiss reported an open-market purchase of 7,000 shares of Common Stock on August 18, 2026, at a weighted average price of $19.194 per share.

Rhea-AI Filing Summary

Core Scientific, Inc./tx (CORZ) director Eric Stanton Weiss reported an open-market purchase of 7,000 shares of Common Stock on August 18, 2026, at a weighted average price of $19.194 per share. After this transaction, he directly holds 259,262 CORZ shares. The price reflects multiple trades between $18.785 and $19.595 per share.

Insider Trade Summary

Net Buyer: 7,000 shares

Net Buy 1 txn

Insider Weiss Eric Stanton

Role Director

Bought 7,000 shs ($134K)

Type	Security	Shares	Price	Value
Purchase	Common Stock F1	7,000	$19.194	$134K

Holdings After Transaction: Common Stock — 259,262 shares (Direct)

Footnotes (1)

1. F1. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.785 to $19.595, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.

Key Figures

Shares purchased: 7,000 shares of Common Stock Weighted average purchase price: $19.194 per share Price range of trades: $18.785 to $19.595 per share +1 more

4 metrics

Shares purchased 7,000 shares of Common Stock Open-market purchase on August 18, 2026

Weighted average purchase price $19.194 per share Average price for the 7,000 CORZ shares purchased

Price range of trades $18.785 to $19.595 per share Range of prices for multiple purchase executions

Shares owned after transaction 259,262 shares Direct ownership by Eric Stanton Weiss after the purchase

Key Terms

weighted average price, Rule 10b5-1, Common Stock

3 terms

weighted average price financial

"The price reported is a <b>weighted average price</b>."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Rule 10b5-1 regulatory

"The document-level Rule <b>10b5-1</b> checkbox is marked false."

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

Common Stock financial

"security_title: "<b>Common Stock</b>""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction in CORZ stock did Eric Stanton Weiss report?

He reported purchasing 7,000 shares of Core Scientific, Inc. (CORZ) Common Stock on August 18, 2026 in an open-market transaction, according to the Form 4 filing.

At what price did Eric Stanton Weiss buy CORZ shares?

The reported weighted average price was $19.194 per share. The shares were bought in multiple trades at prices ranging from $18.785 to $19.595 per share, inclusive.

How many CORZ shares does Eric Stanton Weiss own after this transaction?

Following the reported purchase, Eric Stanton Weiss directly owns 259,262 shares of Core Scientific, Inc. (CORZ) Common Stock, as stated in the Form 4.

Was the recent CORZ insider trade by Eric Stanton Weiss a purchase or a sale?

It was a purchase. The Form 4 lists transaction code P and an acquired/disposed code of A, indicating an open-market or private purchase of CORZ Common Stock.

Were Eric Stanton Weiss’s CORZ trades executed under a Rule 10b5-1 trading plan?

No. The document-level Rule 10b5-1 checkbox is marked false, indicating the reported CORZ transactions were not affirmed as being executed under a 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/20/2026 - 04:14 PM Accepted by SEC EDGAR 08/20/2026 - 04:13 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Weiss Eric Stanton

(Last) (First) (Middle)

C/O CORE SCIENTIFIC, INC.

838 WALKER ROAD, SUITE 21-2105

(Street)

DOVER DELAWARE 19904

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Core Scientific, Inc./tx [ CORZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/18/2026		P		7,000	A	$19.194(1)	259,262	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $18.785 to $19.595, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.

	/s/ Todd DuChene, as Attorney-in-Fact	08/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)